Circulating Tumor Cell News and Research

RSS
Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Researchers improve NanoVelcro device to better grab cancer cells as blood passes by them

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

Scientists develop new nanotechnology to capture, release tumor cells that circulate in bloodstream

China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer

China SFDA approves Veridex’s CellSearch test for women with metastatic breast cancer

U-M devises new system to capture and study circulating tumor cells

U-M devises new system to capture and study circulating tumor cells

Surprising discovery about physical properties of cancer cells

Surprising discovery about physical properties of cancer cells

Study shows how cancer cells control ON/OFF switch of EMT program

Study shows how cancer cells control ON/OFF switch of EMT program

Improvements in rare cell isolation and common blood tests

Improvements in rare cell isolation and common blood tests

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Enzymatic sculpting process used to isolate and concentrate cells from whole blood

Enzymatic sculpting process used to isolate and concentrate cells from whole blood

Lung cancer patients can be screened for ALK-inhibitor suitability

Lung cancer patients can be screened for ALK-inhibitor suitability

Affymetrix second quarter total revenue increases to $66.4 million

Affymetrix second quarter total revenue increases to $66.4 million

BioView, ScreenCell enter collaboration agreement for imaging of CTC

BioView, ScreenCell enter collaboration agreement for imaging of CTC

New optical microscope identifies rare breast cancer cells

New optical microscope identifies rare breast cancer cells

New treatment target against metastatic pancreatic cancer

New treatment target against metastatic pancreatic cancer

Unifying theory on causes of cancer metastases

Unifying theory on causes of cancer metastases

New microfluidic device can sort cancer cells, particles

New microfluidic device can sort cancer cells, particles

Transgenomic introduces ICE COLD-PCR mutation detection technology

Transgenomic introduces ICE COLD-PCR mutation detection technology